In contrast, IDH‐mutant and 1p/19q co‐deleted gliomas, classically classified as oligodendroglioma, presented consistently low levels of CDH3 expression, with only 1.2% and 4.2% of grade II and III cases overexpressing CDH3. The gene discussed is IDH2; the disease is central nervous system cancer.